Evidence map›Paper›PMID 41929240›Full record

Articlenpj biomedical innovations2026

Developing a protocol to counteract spontaneous in vitro activation of intestinal fibroblasts using design of experiments.

Zahra Mohammadalizadeh, Samanvitha Sudi, Daniel A Basto Moreno, Katherine Bauer Estrada, Morgenne Almonte, Kaitlin C Fogg, Ana Maria Porras

Abstract read
In one paragraph

Article in npj biomedical innovations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zahra MohammadalizadehJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL USA.
Samanvitha SudiJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL USA.
Daniel A Basto MorenoJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL USA.
Katherine Bauer EstradaJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL USA.
Morgenne AlmonteJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL USA.
Kaitlin C FoggSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, OR USA.
Ana Maria PorrasJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL USA.

Funding

Microbiota and Extracellular Matrix Interactions that Drive Host Tissue RemodelingR35GM155229 · NIGMS · UNIVERSITY OF FLORIDA · PI Ana Maria Porras · 2024 to 2026
$1.1M
NIGMS NIH HHS R35 GM155229
6 · The paper itself

Abstract

In vitro studies of intestinal fibrosis are confounded by spontaneous fibroblast activation on tissue culture polystyrene, hindering the investigation of early events that initiate fibrosis. Here, we present a statistically optimized culture protocol that suppresses fibroblast activation while preserving cell viability under standard culture conditions. Using a design of experiments (DOE) framework, we systematically evaluated combinations of extracellular matrix proteins and soluble factors to identify conditions that reduce myofibroblastic marker expression and extracellular matrix production. Fibroblasts cultured under optimized conditions remained spindle-shaped, exhibited low myofibroblastic marker expression, and showed reduced collagen and fibronectin secretion without evidence of cytotoxicity. The protocol was further validated in primary human colonic fibroblasts from both male and female donors, yielding consistent suppression of activation markers with high viability. This accessible and scalable approach provides a reproducible baseline for studying fibroblast activation and supports the use of DOE as a powerful strategy for defining microenvironmental conditions that regulate fibroblast behavior in vitro.

Indexed as

Biological techniquesBiotechnologyCell biology

Identifiers

PMID41929240
PMCPMC13038414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.